Next-Generation TKI Approved for Advanced ROS1-Positive Lung Cancer

(MedPage Today) — The FDA approved taletrectinib (Ibtrozi) — a next-generation oral ROS1 tyrosine kinase inhibitor (TKI) — for the treatment of adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC)…

Source link : https://www.medpagetoday.com/hematologyoncology/lungcancer/116021

Author :

Publish date : 2025-06-11 20:19:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Next-Generation TKI Approved for Advanced ROS1-Positive Lung Cancer

Tulane Scientist Resigns, Cites Censorship of Pollution and Disparities Research

Oncology Community Rallies, Rails Against ‘Draconian’ Budget Cuts for NIH, NCI

Related Posts

The Undervalued Medical Power of Muscle

AMA Calls for ACIP Answers, Stable Federal Funding

Docs Should Turn Away From ACIP’s Vaccine Recommendations, Ex-Member Says

RFK Jr. Plans to Pull Medical Schools’ Funding if They Don’t Teach Nutrition

Early FIT Linked to Reduced Colon Cancer Incidence, Mortality

Mavyretz Approved for Acute Hepatitis C; ALD Deaths Double; Entyvio in Pregnancy

The Undervalued Medical Power of Muscle

AMA Calls for ACIP Answers, Stable Federal Funding

Docs Should Turn Away From ACIP’s Vaccine Recommendations, Ex-Member Says

RFK Jr. Plans to Pull Medical Schools’ Funding if They Don’t Teach Nutrition

Early FIT Linked to Reduced Colon Cancer Incidence, Mortality

Mavyretz Approved for Acute Hepatitis C; ALD Deaths Double; Entyvio in Pregnancy

Why John Stewart Bell has been haunting quantum mechanics for decades

Non-Surgical Option Approved for Recurrent Low-Grade Bladder Cancer

Categories

Archives